CorVel Corp. 10-Q Summary: Quarter Ended June 30, 1998
Business Context and Reporting Period
This Form 10-Q covers the first quarter of CorVel Corporation's fiscal year ending March 31, 1999, specifically the three months ended June 30, 1998. CorVel provides managed care services, primarily focusing on workers' compensation and patient management programs. As of June 30, 1998, there were 4,085,000 shares of Common Stock outstanding.
Key Financial Metrics
| Metric | Q1 1998 | Q1 1997 |
|---|---|---|
| Revenues | $39,552,000 | $34,027,000 |
| Gross Profit | $32,342,000 | $27,557,000 |
| Gross Margin | 18.2% | 19.0% |
| Net Income | $2,501,000 | $2,275,000 |
| Diluted EPS | $0.60 | $0.52 |
| Operating Cash Flow | $1,389,000 | $2,045,000 |
| Cash and Equivalents (End of Period) | $6,408,000 | $12,429,000 |
| Total Assets | $61,157,000 | $60,491,000 (Mar 31, 1998) |
| Working Capital | $25,233,000 | $24,726,000 (Mar 31, 1998) |
Note: The filing does not explicitly list total debt figures; the balance sheet shows no long-term debt, only current liabilities and deferred taxes.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 14% to $39.6 million, driven by a 22% increase in patient management revenue and a 9% increase in provider program revenues.
- Margin Compression: Gross profit margin declined to 18.2% from 19.0%. This was caused by a higher growth rate in patient management services, which carry lower margins compared to provider program revenues.
- Cash Position: Cash and cash equivalents decreased by $2.0 million to $6.4 million. This decline is primarily attributed to the repurchase of $2.3 million of common stock during the quarter.
- Operating Expenses: General and administrative expenses increased 14% to $7.2 million, but as a percentage of revenue, they decreased slightly from 8.2% to 8.0%.
Outlook, Risks, and Management Commentary
Management Commentary: Management notes that while revenue growth is positive, the rate is slower than in previous years, partially due to a national reduction in healthcare expenditure growth. The company funded operations and capital expenditures through cash flow and believes current cash balances plus borrowing capacity are sufficient for the next 12 months.
Risks and Contingencies:
- Regulatory Changes: Evolving state laws regarding medical review services and managed care networks could increase operational costs or require new licensing.
- Legislative Reform: Proposals to combine workers' compensation with traditional health plans (24-hour coverage) could adversely affect demand for CorVel's services.
- Competition: Increased competition from HMOs, PPOs, and insurers entering the workers' compensation market.
- Legal Liability: Potential litigation regarding medical treatment recommendations, though the company maintains professional liability insurance.
- Stock Volatility: The company warns that stock price may be volatile due to variations in earnings and general market trends.
Investor Verification Checklist
- Verify the sustainability of the 22% growth in patient management revenue versus the margin erosion it caused.
- Confirm the impact of the $2.3 million stock repurchase on future liquidity and capital allocation strategy.
- Monitor state-level legislative changes regarding workers' compensation and managed care licensing that could increase compliance costs.
- Assess the company's ability to maintain growth rates in a national environment of slowing healthcare expenditure growth.
- Review the status of ongoing litigation to ensure no material liabilities have emerged since the filing date.